Chemical Structure (Rom04 0001 01)
Romvimza Capsule
Product Images NDC 73207-302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Romvimza (NDC 73207-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Deciphera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Rom04 0001 02)
Principal Display Panel – 14 mg Carton Label (Rom04 0001 03)
Each capsule contains 14 mg of vimseltinib. The recommended dosage is provided in the prescribing information. Swallow the capsules whole and do not open, break, or chew them. This package is child-resistant and should be kept out of reach of children. The capsules should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is manufactured for and marketed by Deciphera Pharmaceuticals in Waltham, MA. For more information, visit the website or call the provided number. The capsules are a 4-week supply containing 8 capsules per blister pack.*
Principal Display Panel – 20 mg Carton Label (Rom04 0001 04)
This text provides information about a medication called Romvimza, which contains vimseltinib. Each capsule contains 20 mg of vimseltinib. The recommended dosage is not provided and refers to the prescribing information for details. It is important to swallow the capsules whole and not open, break, or chew them. The medication should be kept out of reach of children as the packaging is child-resistant. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The manufacturing and marketing are handled by Deciphera Pharmaceuticals, LLC based in Waltham, MA. Contact details for further information or inquiries are available at www.romvimza.com or by calling 1-888-724-8274.*
Principal Display Panel – 30 mg Carton Label (Rom04 0001 05)
Each capsule of Romvimza contains 30 mg of vimseltinib. The recommended dosage is specified in the prescribing information. The capsules should be swallowed whole and should not be opened, broken, or chewed. The package is child-resistant to ensure safety. Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Romvimza is manufactured for and marketed by Deciphera Pharmaceuticals in Waltham, MA. For more information, visit www.romvimza.com or call 1-888-724-8274.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
